athenahealth (Nasdaq: ATHN) is expected to report Q2 earnings on July 18. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict athenahealth's revenues will expand 43.1% and EPS will shrink -8.3%.

The average estimate for revenue is $148.1 million. On the bottom line, the average EPS estimate is $0.22.

Revenue details
Last quarter, athenahealth notched revenue of $125.6 million. GAAP reported sales were 30% higher than the prior-year quarter's $96.6 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.38. GAAP EPS of $0.02 for Q1 were 71% lower than the prior-year quarter's $0.07 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 57.7%, 210 basis points worse than the prior-year quarter. Operating margin was -4.9%, much worse than the prior-year quarter. Net margin was 0.6%, 190 basis points worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $597.5 million. The average EPS estimate is $1.10.

Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 201 members out of 256 rating the stock outperform, and 55 members rating it underperform. Among 73 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 61 give athenahealth a green thumbs-up, and 12 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on athenahealth is hold, with an average price target of $91.54.

Is athenahealth the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.